It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their U.S.
Evaluate’s latest analysis forecasts an $82 billion increase in major product revenues in 2025 – the largest annual growth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback